36
P. Van Antwerpen et al. / European Journal of Pharmacology 537 (2006) 31–36
Burner, U., Jantschko, W., Obinger, C., 1999. Kinetics of oxidation of aliphatic
and aromatic thiols by myeloperoxidase compounds I and II. FEBS Lett.
443, 290–296.
Kettle, A.J., Winterbourn, C.C., 1988. Superoxide modulates the activity of
myeloperoxidase and optimises the production of hypochlorous acid.
Biochem. J. 252, 529–536.
Carr, A.C., Myzak, M.C., Stocker, R., McCall, M.R., Frei, B., 2000.
Myeloperoxidase binds to low-density lipoprotein: potential implications
for atherosclerosis. FEBS Lett. 487, 176–180.
Carr, A.C., Decker, E.A., Park, Y., Frei, B., 2001. Comparison of low-density
lipoprotein modification by myeloperoxidase-derived hypochlorous and
hypobromous acids. Free Radic. Biol. Med. 31, 62–72.
Malle, E., Waeg, G., Schreiber, R., Gröne, E.F., Sattler, W., Gröne, H.-J., 2000.
Immunohistochemical evidence for the myeloperoxidase/H2O2/halide
system in human atherosclerotic lesions. Eur. J. Biochem. 267, 4495–4503.
Marquez, L.A., Huang, J.T., Dunford, H.B., 1994. Spectral and kinetic studies
on the formation of myeloperoxidase compounds I and II: roles of hydrogen
peroxide and superoxide. Biochemistry 33, 1447–1454.
Chisolm, G.M., Steinberg, D., 2000. The oxidative modification hypothesis of
atherogenesis: an overview. Free Radic. Biol. Med. 28, 1815–1826.
De Nigris, F., D'armiento, F.P., Somma, P., Casini, A., Andreini, I., Sarlo, F.,
Mansueto, G., De Rosa, G., Bonaduce, D., Condorelli, M., Napoli, C., 2001.
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors
reduce susceptibility of plasma LDL to in vitro oxidation, formation of
oxidation-specific epitopes in the artrial wall, and atherogenesis in
apolipoprotein E knockout mice. Int. J. Cardiol. 81, 107–115.
Fernandes, A.C., Filipe, P.M., Freitas, J.P., Manso, C.F., 1996. Different effects
of thiol and nonthiol ACE inhibitors on copper-induced lipid and protein
oxidative modification. Free Radic. Biol. Med. 20, 507–514.
Folkes, L.K., Candeias, P., Wardman, P., 1995. Kinetics and mechanisms of
hypochlorous acid reactions. Arch. Biochem. Biophys. 323, 120–126.
Furtmüller, P.G., Burner, U., Jantschko, W., Regelsberger, G., Obinger, C.,
2000. Two-electron reduction and one-electron oxidation of organic
hydroperoxides by human myeloperoxidase. FEBS Lett. 484, 139–143.
Gana, M., Panderi, I., Pariisi-Poulou, M., Tsantili-Kakoulidou, A., 2002.
Kinetics of the acidic and enzymatic hydrolysis of benazepril HCl studied by
LC. J. Pharm. Biomed. Anal. 27, 107–116.
Gressier, B., Lebegue, N., Brunet, C., Luyckx, M., Dine, T., Cazin, M., Cazin, J.C.,
1995. Scavenging of reactive oxygen species by letosteine, a molecule with
two blocked -SH groups. Pharm. World Sci. 3, 76–80.
Havel, R.J., Eder, H.A., Bragdom, J.H., 1955. The distribution and chemical
composition of ultracentrifugally separated lipoprotein in human serum.
J. Clin. Invest. 34, 1345–1353.
Hazell, J.L., Van den Berg, J.J.M., Stocker, R., 1994. Oxidation of low density
lipoprotein by hypochlorite causes aggregation that is mediated by
modification of lysine residues rather than lipid oxidation. Biochem. J. 304,
297–304.
Hewson, W.D., Hager, L.P., 1979. Mechanism of the chlorination reaction
catalyzed by horseradish peroxidase with chloride. J. Biol. Chem. 254,
3175–3181.
Moguilevsky, N., Garcia-Quintana, L., Jacquet, A., Tournay, C., Fabry, L.,
Pierard, L., Bollen, A., 1991. Structural and biological properties of human
recombinant myeloperoxidase produced by Chinese hamster ovary cell
lines. Eur. J. Biochem. 197, 605–614.
Moguilevsky, N., Zouaoui Boudjeltia, K., Babar, S., Delree, P., Lessgyer, I.,
Carpentier, Y., Vanhaeverbeek, M., Ducobu, J., 2004. Monoclonal
antibodies against LDL progressively oxidized by myeloperoxidase react
with ApoB-100 protein moiety and human atherosclerotic lesions. Biochem.
Biophys. Res. Commun. 323, 1223–1228.
Nève, J., Parij, N., Moguilevsky, N., 2001. Inhibition of the myeloperoxidase
chlorinating activity by non-steroidal anti-inflammatory drugs investigated
with a human recombinant enzyme. Eur. J. Pharm. 417, 37–43.
Peskin, A.V., Winterbourn, C.C., 2001. Kinetics of the reactions of
hypochlorous acid and amino acid chloramines with thiols, methionine
and ascorbate. Free Radic. Biol. Med. 30, 572–579.
Peterson, G.L., 1977. A simplification of the protein assay method of Lowry
et al. which is more generally applicable. Anal. Biochem. 83, 346–356.
Podrez, E.A., Abu-Soud, H.M., Hazen, S.L., 2000. Myeloperoxidase-generated
oxidants and atherosclerosis. Free Radic. Biol. Med. 28, 1717–1725.
Ueda, M., Ehara, S., Kobayashi, Y., Naruko, T., Shirai, N., Hai, E., Ikura, Y.,
Ohsawa, M., Becker, A.E., 2004. Plaque instability in human coronary
atherosclerotic lesions: roles of oxidized LDL and neutrophils. Int. Congr.
Ser. 1262, 75–78.
Van Antwerpen, P., Zouaoui Boudjeltia, K., Babar, S., Legssyer, I., Moreau, P.,
Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., Nève, J., 2005. Thiol-
containing molecule interact with the MPO / H2O2 / chloride system to
inhibit LDL oxidation. Biochem. Biophys. Res. Commun. 337, 82–88.
Vanderbist, F., Maes, P., Nève, J., 1996. In vitro comparative assessment of the
antioxidant activity of Nacystelyn against three reactive oxygen species.
Arzneim.-Forsch. Drug Res. 46, 783–788.
Winterbourn, C.C., Kettle, A.J., 2000. Biomarkers of myeloperoxidase-derived
hypochlorous acid. Free Radic. Biol. Med. 29, 403–409.
Jankowski, A., Skorek, A., Krzysko, K., Zarzycki, R.J., Lamparczyk, H., 1995.
Captopril: determination in blood and pharmacokinetics after single oral
dose. J. Pharm. Biomed. Anal. 13, 600–655.
Jemal, M., Ivashkiv, E., Ribick, M., Cohen, A.I., 1985. Determination of sq
27,519, the active phosphinic acid-carboxylic acid of the prodrug sq 28,555,
in human serum by capillary gas chromatography with nitrogen-phosphorus
detection after a two-step derivatization. J. Chromatogr., Biomed. Appl. 345,
299–307.
Yang, C., Gu, Z., Yang, M., Lin, S., Garcia-Prats, A.J., Rogers, L.K., Welty, S.E.,
Smith, C.V., 1999. Selective modification of apoB-100 in the oxidation of low
density lipoproteins by myeloperoxidase in vitro. J. Lipid. Res. 40, 686–698.
Zouaoui Boudjeltia, K., Moguilevsky, N., Legssyer, I., Babar, S., Guillaume,
M., Delree, P., Vanhaeverbeek, M., Brohee, D., Ducobu, J., Remacle, C.,
2004. Oxidation of low density lipoproteins by myeloperoxidase at the
surface of endothelial cells: an additional mechanism to subendothelium
oxidation. Biochem. Biophys. Res. Commun. 325, 434–438.
Jerlich, A., Tschabuschnig, S., Fabjan, J.S., Schaur, R.J., 2000. Kinetics of
chlorination of monochlorodimedone by myeloperoxidase. Int. J. Clin. Lab.
Res. 30, 33–37.